GU CONNECT expert, Assoc. Prof. Shilpa Gupta provides a urothelial cancer update from ASCO GU 2020 for you.


Urothelial cancer update by Assoc. Prof. Shilpa Gupta, University of Minnesota, Minneapolis, USA

 

Shilpa Gupta, MD is an Associate Professor in the Division of Hematology, Oncology and Transplantation and the lead for the Phase 1 Interdisciplinary Solid Tumor Program at the Masonic Cancer Center, University of Minnesota, Minneapolis, USA. Prior to joining the University of Minnesota in July 2015, Dr Gupta was faculty in Genitourinary Oncology and Experimental Therapeutics at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida for 4 years. Dr Gupta’s clinical and research interests are to treat patients with genitourinary malignancies and develop novel trials using targeted therapies and immunotherapies. She is currently the Principal investigator of several early and late phase trials in genitourinary oncology. Dr Gupta is passionate about her research and has published her research across a variety of peer-reviewed journals and book chapters. Twitter: @shilpaonc Email:guptash@umn.edu

Programme summary
Watch the video now
Other episodes of this series
GU CONNECT: Update from ASCO GU 2020

GU CONNECT: Update from ASCO GU 2020

Episode 1: Prostate Cancer
GU CONNECT Update from ASCO GU 2020

GU CONNECT Update from ASCO GU 2020

Episode 2: Urothelial Cancer Current Episode
GU CONNECT Update from ASCO GU 2020

GU CONNECT Update from ASCO GU 2020

Episode 3: Kidney Cancer
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GU CONNECT

GU CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

conference-update Conference update
Oncology 
Update from ESGO 2026 – PYNNACLE Phase 2 study: Interim results from the ovarian cancer cohort

Clinical insights and expert discussion

Experts
Prof. Domenica Lorusso, Prof. Jean-Sebastien Frenel
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Mar 2026

This programme has been sponsored by PMV Pharma and is intended for HCPs only.
publication Scientific Publication
Oncology 
ADCs in HER2+ metastatic breast cancer and management of adverse events

Consensus-based guidance for clinicians and patients

Experts
Prof. Javier Cortés, Prof. Giuseppe Curigliano, Prof. Shaheenah Dawood, Dr Grażyna Suchodolska, Dr Sara Tolaney, Carla Whitbread
Endorsed by
EONS - European Oncology Nursing Society Europa Donna
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Feb 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from AstraZeneca
expert-video-animation Animated Video
Oncology Obstetrics and Gynecology 
Understanding HER2 testing in gynecological cancers

Best practices and treatment implications

Experts
Prof. Fernando A. Soares
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative
  • download Downloadable
    Resources
  • clock 8 MIN
  • calendar Feb 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Daiichi Sankyo.
symposium Masterclass / SymposiumVideo overview
Oncology 
ER+/HER2- metastatic breast cancer: Highlights from the APBCS 2026 Satellite Symposium

Experts discuss 2L+ treatment strategies in endocrine therapy-eligible patients

Experts
Dr Mastura Md Yusof, Dr Hope S. Rugo, Prof. Matteo Lambertini
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jan 2026

This programme has been sponsored by Menarini Stemline and is intended for HCPs only